Key Highlights
- Solésence, Inc. Will remit an amount equivalent to $938,000, expressed in British pounds, to Refy Beauty under the settlement.
- The payment plan consists of twelve installments of $78,166.66 each, with the first due on August 5, 2026.
- The agreement grants a six‑month exclusivity window for developing a new SPF product, with the option to convert the last six installments into product credits.
Solésence, Inc. disclosed a settlement with Refy Beauty Ltd that resolves prior disputes over consumer‑care items previously supplied. Under the terms, Solésence is obligated to deliver a sum that amounts to $938,000, converted into pounds, across a series of twelve payments.
Settlement Overview
The deal clears all outstanding claims linked to earlier product transactions between the two companies. By fixing the total amount, Solésence seeks to eliminate litigation risk while maintaining a collaborative relationship with Refy Beauty.
Payment Schedule
The company will commence disbursing $78,166.66 per instalment, with the inaugural payment scheduled for August 5, 2026. Subsequent payments will follow on a roughly monthly cadence, finalising after twelve cycles.
Exclusivity Window
Both parties have agreed to a six‑month exclusivity period centred on the development of a new SPF‑based consumer product. During this time, neither side may partner with competing firms for similar product development initiatives.
Potential Supply Agreement
Should negotiations evolve into a formal supply contract for the SPF product, the remaining six instalments may be applied as a credit toward the purchase price. This structure aligns the financial settlement with prospective commercial collaboration.
Regulatory Filing Timeline
The settlement agreement was initially executed on July 6, 2026, with the accompanying disclosure signed on July 10, 2026. These dates situate the transaction within the current reporting period.
Market Implications
Industry analysts view the settlement as a strategic move to stabilise Solésence’s supply chain and concentrate resources on high‑growth SPF offerings. Converting future payments into product credits could improve margin performance while reinforcing brand synergy with Refy Beauty.
Sector Context
The personal‑care market continues to witness heightened consumer interest in sun‑protection formulations, driven by regulatory emphasis on broad‑spectrum efficacy. Companies that secure reliable ingredient sources and streamline product pipelines are better positioned to capitalize on this trend. Solésence’s collaboration with Refy Beauty may therefore serve as a template for other firms seeking to merge settlement resolution with forward‑looking product development.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.






Please wait processing your request...